BAX files SEC form for Baxalta (pharma segment) spinoff: http://www.sec.gov/Archives/edgar/data/1620546/000119312514439061/d829725dex991.htm After the spinoff is completed in 2015, what remains part of BAX will constitute a pretty good play on the global diabetes epidemic (#msg-106316378).